Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance
Phase 3
Completed
- Conditions
- Prediabetic State
- Interventions
- Dietary Supplement: Vanadyl sulfateOther: Magnesium oxide
- Registration Number
- NCT00561132
- Lead Sponsor
- Unidad de Investigacion Medica en Epidemiologia Clinica
- Brief Summary
The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
- Diagnosis of impaired glucose tolerance
- Body mass index from 25 to 35 kg/m2
- History of type 2 diabetes mellitus in the first branch
Exclusion Criteria
- Taking medication with known effects on carbohydrate or insulin metabolism
- Thyroid diseases
- Hepatic diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Vanadyl sulfate - 2 Magnesium oxide -
- Primary Outcome Measures
Name Time Method Changes on insulin sensitivity assessed with a euglycemic-hyperinsulinemic clamp technique 4 weeks
- Secondary Outcome Measures
Name Time Method Changes on metabolic profile 4 weeks Changes on anthropometrical measures 4 weeks
Trial Locations
- Locations (1)
Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, UMAE, Centro Medico Nacional de Occidente
🇲🇽Guadalajara, Jalisco, Mexico